These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 33270611)

  • 1. Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions - New Jersey, February-July 2020.
    Perez S; Innes GK; Walters MS; Mehr J; Arias J; Greeley R; Chew D
    MMWR Morb Mortal Wkly Rep; 2020 Dec; 69(48):1827-1831. PubMed ID: 33270611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and molecular characterization of Acinetobacter baumannii isolates causing lower respiratory infections among ICU patients.
    Jain M; Sharma A; Sen MK; Rani V; Gaind R; Suri JC
    Microb Pathog; 2019 Mar; 128():75-81. PubMed ID: 30562602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for nosocomial rectal colonization with carbapenem-resistant Acinetobacter baumannii in hospital: a matched case-control study.
    Meschiari M; Kaleci S; Orlando G; Selmi S; Santoro A; Bacca E; Menozzi M; Franceschini E; Puzzolante C; Bedini A; Sarti M; Venturelli C; Vecchi E; Mussini C
    Antimicrob Resist Infect Control; 2021 Apr; 10(1):69. PubMed ID: 33832538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Containment of a carbapenem-resistant Acinetobacter baumannii complex outbreak in a COVID-19 intensive care unit.
    Eckardt P; Canavan K; Guran R; George E; Miller N; Avendano DH; Kim M; Himed K; Ramirez KHG
    Am J Infect Control; 2022 May; 50(5):477-481. PubMed ID: 35227793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The challenge of preventing and containing outbreaks of multidrug-resistant organisms and Candida auris during the coronavirus disease 2019 pandemic: report of a carbapenem-resistant Acinetobacter baumannii outbreak and a systematic review of the literature.
    Thoma R; Seneghini M; Seiffert SN; Vuichard Gysin D; Scanferla G; Haller S; Flury D; Boggian K; Kleger GR; Filipovic M; Nolte O; Schlegel M; Kohler P
    Antimicrob Resist Infect Control; 2022 Jan; 11(1):12. PubMed ID: 35063032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence and prevalence of hospital-acquired (carbapenem-resistant)
    Ayobami O; Willrich N; Harder T; Okeke IN; Eckmanns T; Markwart R
    Emerg Microbes Infect; 2019; 8(1):1747-1759. PubMed ID: 31805829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Acinetobacter baumannii in Saudi Arabia: risk factors, antimicrobial resistance patterns and mechanisms of carbapenem resistance.
    Ibrahim ME
    Ann Clin Microbiol Antimicrob; 2019 Jan; 18(1):1. PubMed ID: 30606201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental colonization and onward clonal transmission of carbapenem-resistant
    Ng DHL; Marimuthu K; Lee JJ; Khong WX; Ng OT; Zhang W; Poh BF; Rao P; Raj MDR; Ang B; De PP
    Antimicrob Resist Infect Control; 2018; 7():51. PubMed ID: 29644052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenem-resistant versus carbapenem-susceptible Acinetobacter baumannii bacteremia in a Greek intensive care unit: risk factors, clinical features and outcomes.
    Routsi C; Pratikaki M; Platsouka E; Sotiropoulou C; Nanas S; Markaki V; Vrettou C; Paniara O; Giamarellou H; Roussos C
    Infection; 2010 Jun; 38(3):173-80. PubMed ID: 20224962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal spread of carbapenem-resistant Acinetobacter baumannii in a neonatal intensive care unit.
    Maciel WG; da Silva KE; Croda J; Cayô R; Ramos AC; de Sales RO; de Almeida de Souza GH; Bampi JVB; Limiere LC; Casagrande JC; Gales AC; Simionatto S
    J Hosp Infect; 2018 Mar; 98(3):300-304. PubMed ID: 29107079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management and control of a carbapenem-resistant Acinetobacter baumannii outbreak in an intensive care unit.
    Alfandari S; Gois J; Delannoy PY; Georges H; Boussekey N; Chiche A; Meybeck A; Patoz P; Blondiaux N; Senneville E; Melliez H; Leroy O
    Med Mal Infect; 2014 May; 44(5):229-31. PubMed ID: 24840286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic Characterization of Carbapenem-Resistant Acinetobacter baumannii (CRAB) in Mechanically Ventilated COVID-19 Patients and Impact of Infection Control Measures on Reducing CRAB Circulation during the Second Wave of the SARS-CoV-2 Pandemic in Milan, Italy.
    Mangioni D; Fox V; Chatenoud L; Bolis M; Bottino N; Cariani L; Gentiloni Silverj F; Matinato C; Monti G; Muscatello A; Teri A; Terranova L; Piatti A; Gori A; Grasselli G; Stocchetti N; Alteri C; Bandera A
    Microbiol Spectr; 2023 Mar; 11(2):e0020923. PubMed ID: 36976013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit.
    Meschiari M; Lòpez-Lozano JM; Di Pilato V; Gimenez-Esparza C; Vecchi E; Bacca E; Orlando G; Franceschini E; Sarti M; Pecorari M; Grottola A; Venturelli C; Busani S; Serio L; Girardis M; Rossolini GM; Gyssens IC; Monnet DL; Mussini C
    Antimicrob Resist Infect Control; 2021 Aug; 10(1):123. PubMed ID: 34412693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study.
    Chusri S; Silpapojakul K; McNeil E; Singkhamanan K; Chongsuvivatwong V
    J Infect Chemother; 2015 Feb; 21(2):90-5. PubMed ID: 25454216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-year molecular surveillance of carbapenem-susceptible
    Wendel AF; Malecki M; Otchwemah R; Tellez-Castillo CJ; Sakka SG; Mattner F
    Antimicrob Resist Infect Control; 2018; 7():145. PubMed ID: 30505434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbapenem resistance in Acinetobacter baumannii: the molecular epidemic features of an emerging problem in health care facilities.
    Zarrilli R; Giannouli M; Tomasone F; Triassi M; Tsakris A
    J Infect Dev Ctries; 2009 Jun; 3(5):335-41. PubMed ID: 19759502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective multi-center evaluation on risk factors, clinical characteristics and outcomes due to carbapenem resistance in
    Liu Y; Wang Q; Zhao C; Chen H; Li H; Wang H; Cares Network OBOT
    J Med Microbiol; 2020 Jul; 69(7):949-959. PubMed ID: 32584215
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014.
    Mahamat A; Bertrand X; Moreau B; Hommel D; Couppie P; Simonnet C; Kallel H; Demar M; Djossou F; Nacher M
    Int J Antimicrob Agents; 2016 Jul; 48(1):51-55. PubMed ID: 27236843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years.
    Park YK; Jung SI; Park KH; Kim DH; Choi JY; Kim SH; Ko KS
    J Med Microbiol; 2012 Jan; 61(Pt 1):71-79. PubMed ID: 21852525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and epidemiological characterisation of clinical isolates of carbapenem-resistant Acinetobacter baumannii from public and private sector intensive care units in Karachi, Pakistan.
    Irfan S; Turton JF; Mehraj J; Siddiqui SZ; Haider S; Zafar A; Memon B; Afzal O; Hasan R
    J Hosp Infect; 2011 Jun; 78(2):143-8. PubMed ID: 21459477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.